NCT00409175 Safety and Efficacy Study of Fx-1006A in Patients With Familial Amyloidosis Status COMPLETED Phase PHASE2/PHASE3
NCT00408954 Urodynamic Effects of UK-369,003 in Men With Lower Urinary Tract Symptoms Status COMPLETED Phase PHASE2
NCT00407784 Diagnostic Properties of Aldosterone-Renin Ratio in Primary Aldosteronism Among Hypertensives. Status UNKNOWN Phase N/A
NCT00406952 Study for Evaluating Different Methods of Measuring Depression Treatment Response Status COMPLETED Phase NA
NCT00406107 Evaluation of Macugen Treatment of Macular Edema Due to Branch Retinal Vein Occlusion Status COMPLETED Phase PHASE4
NCT00404495 Combination of Irinotecan and Temozolomide in Children With Brain Tumors. Status COMPLETED Phase PHASE2
NCT00403546 High-Dose Oral Ziprasidone Versus Conventional Dosing in Participants With Residual Schizophrenia Symptoms Status COMPLETED Phase PHASE3
NCT00402493 Study to Determine if Taking OTC Non-Steroidal Anti-Inflammatory Affects Eye Pressure in Patients Using Glaucoma Drops Status COMPLETED Phase NA
NCT00402415 Study of Combination of Sirolimus and Sutent in Patients With Advanced Solid Tumors Non-Curable With Standard Therapy Status TERMINATED Phase PHASE1
NCT00401362 A a Single Dose Efficacy Study in Inducing Laxation in Advance Illness Patients Status COMPLETED Phase PHASE3
NCT00401245 The Effect Of Dose Titration And Dose Tapering On The Tolerability Of DVS SR In Women With Vasomotor Symptoms Status COMPLETED Phase PHASE3
NCT00401232 Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Serum Bactericidal Activity Assay Development Status COMPLETED Phase NA
NCT00400569 Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma Status COMPLETED Phase PHASE2
NCT00400114 Sutent Following Chemotherapy, Radiation and Surgery For Resectable Esophageal Cancer Status COMPLETED Phase PHASE2
NCT00397488 Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the Urothelium Status COMPLETED Phase PHASE2
NCT00396474 Safety Study In Patients Who Were Born Small And Short And Were Treated With Growth Hormone To Achieve Normal Height Status WITHDRAWN Phase N/A
NCT00396448 Effect of 2-year Administration of CP-945,598 on Weight Loss Efficacy and Safety. Status TERMINATED Phase PHASE3
NCT00396097 Individualized, Target-Driven Treatment Of Children With Idiopathic Short Stature Status COMPLETED Phase PHASE3